165 related articles for article (PubMed ID: 22533678)
1. Multiple myeloma and its therapies: to what extent do they contribute to the increased incidence of second malignant neoplasms?
Dasanu CA; Mewawalla P; Grabska J
Curr Med Res Opin; 2012 Jul; 28(7):1129-40. PubMed ID: 22533678
[TBL] [Abstract][Full Text] [Related]
2. [Association of multiple myeloma and solid neoplasms: analysis of 13 cases].
Todolí Parra JA; Campo López C; Segura Huerta A; Alonso Estellés R; Saro Pérez E; Torrego Giménez A; Santaballa Bertrán A; Pastor Borgoñón M; Calabuig Alborch JR
Rev Clin Esp; 1999 Nov; 199(11):725-8. PubMed ID: 10638237
[TBL] [Abstract][Full Text] [Related]
3. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
[TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma and other malignancies: a pilot study from the Houston VA.
Munker R; Shi R; Lin D; Guo S; Hayes TG
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):102-6. PubMed ID: 24373789
[TBL] [Abstract][Full Text] [Related]
5. Observations of second primary malignancy in patients with multiple myeloma.
Ormerod A; Fausel CA; Abonour R; Kiel PJ
Clin Lymphoma Myeloma Leuk; 2012 Apr; 12(2):113-7. PubMed ID: 22178548
[TBL] [Abstract][Full Text] [Related]
6. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
8. Immune alterations in untreated and treated multiple myeloma.
Dasanu CA
J Oncol Pharm Pract; 2012 Jun; 18(2):257-63. PubMed ID: 21859744
[TBL] [Abstract][Full Text] [Related]
9. Secondary hematological malignancies after treatment of non-metastatic breast cancer.
Arslan C; Ozdemir E; Dogan E; Ozisik Y; Altundag K
J BUON; 2011; 16(4):744-50. PubMed ID: 22331732
[TBL] [Abstract][Full Text] [Related]
10. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature.
Atienza JA; Dasanu CA
Curr Med Res Opin; 2012 Dec; 28(12):1899-909. PubMed ID: 23121148
[TBL] [Abstract][Full Text] [Related]
11. [Second malignancies in patients treated for Hodgkin's disease].
Keresztes K; Miltényi Z; András C; Illés A
Magy Onkol; 2002; 46(3):247-51. PubMed ID: 12368920
[TBL] [Abstract][Full Text] [Related]
12. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
13. [Breast cancer in men: incidence and types of associated previous synchronous and metachronous cancers].
Cutuli BF; Lacroze M; Dilhuydy JM; Florentz P; Velten M; Allavena C; De Lafontan B; Resbeut M; Campana F; Graic Y
Bull Cancer; 1992; 79(7):689-96. PubMed ID: 1467595
[TBL] [Abstract][Full Text] [Related]
14. Melanoma and additional primary cancers.
Retsas S; Mohith A; Bell J; Horwood N; Alexander H
Melanoma Res; 2000 Apr; 10(2):145-52. PubMed ID: 10803715
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
16. [Second primary malignancies after the treatment of multiple myeloma].
Makita S; Maruyama D
Nihon Rinsho; 2015 Jan; 73(1):162-6. PubMed ID: 25626323
[TBL] [Abstract][Full Text] [Related]
17. The association between renal cell carcinoma and multiple myeloma: insights from population-based data.
Ojha RP; Evans EL; Felini MJ; Singh KP; Thertulien R
BJU Int; 2011 Sep; 108(6):825-30. PubMed ID: 21091979
[TBL] [Abstract][Full Text] [Related]
18. Subsequent malignant neoplasms in cancer survivors.
Ng AK; Travis LB
Cancer J; 2008; 14(6):429-34. PubMed ID: 19060610
[TBL] [Abstract][Full Text] [Related]
19. [Risk of cancer and malignant transformation in hematology practice].
Várkonyi J
Orv Hetil; 2002 Oct; 143(43):2435-8. PubMed ID: 12455145
[TBL] [Abstract][Full Text] [Related]
20. Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families.
Ogmundsdóttir HM; Haraldsdóttirm V; Jóhannesson GM; Olafsdóttir G; Bjarnadóttir K; Sigvaldason H; Tulinius H
Haematologica; 2005 Jan; 90(1):66-71. PubMed ID: 15642671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
